Literature DB >> 10800280

Assessment of serum albumin concentration as a risk factor for stroke and coronary disease in African Americans and whites.

R F Gillum1.   

Abstract

Relatively high serum albumin levels compared to low levels have been associated with reduced cardiovascular mortality and coronary heart disease and stroke incidence. The nature of these associations remains undefined. Therefore, widely accepted criteria of Bradford Hill were used to assess the likelihood that the association is a causal one. These criteria were applied to the findings of published studies of serum albumin and risk of cardiovascular disease. Favoring a causal association are lack of temporal ambiguity in cohort studies, consistency of findings among studies and biologically plausible mechanisms. Not favoring a causal association are lack of specificity of the association, and inconsistency among age-, sex-groups. Further studies are needed to elucidate mechanisms for the effect of serum albumin on incidence of cardiovascular disease and death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10800280      PMCID: PMC2640508     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  38 in total

Review 1.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

2.  Causes.

Authors:  K J Rothman
Journal:  Am J Epidemiol       Date:  1976-12       Impact factor: 4.897

3.  Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes.

Authors:  A Phillips; A G Shaper; P H Whincup
Journal:  Lancet       Date:  1989-12-16       Impact factor: 79.321

Review 4.  Albumin--an important extracellular antioxidant?

Authors:  B Halliwell
Journal:  Biochem Pharmacol       Date:  1988-02-15       Impact factor: 5.858

5.  Geographical distribution of cerebrovascular disease mortality and food intakes in Japan.

Authors:  T Omura; S Hisamatsu; Y Takizawa; M Minowa; H Yanagawa; I Shigematsu
Journal:  Soc Sci Med       Date:  1987       Impact factor: 4.634

6.  Relation of body size and composition to clinical biochemical and hematologic indices in US men and women.

Authors:  M S Micozzi; D Albanes; R G Stevens
Journal:  Am J Clin Nutr       Date:  1989-12       Impact factor: 7.045

7.  Continuous monitoring of in vitro oxidation of human low density lipoprotein.

Authors:  H Esterbauer; G Striegl; H Puhl; M Rotheneder
Journal:  Free Radic Res Commun       Date:  1989

8.  The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial.

Authors:  L H Kuller; J E Eichner; T J Orchard; G A Grandits; L McCallum; R P Tracy
Journal:  Am J Epidemiol       Date:  1991-12-01       Impact factor: 4.897

9.  Serum albumin, coronary heart disease, and death.

Authors:  R F Gillum; D M Makuc
Journal:  Am Heart J       Date:  1992-02       Impact factor: 4.749

10.  Systemic effects associated with intermittent claudication. A model to study biochemical aspects of vascular disease?

Authors:  C P Shearman; P Gosling; B R Gwynn; M H Simms
Journal:  Eur J Vasc Surg       Date:  1988-12
View more
  9 in total

1.  Impact of serum albumin levels on long-term outcomes in patients undergoing percutaneous coronary intervention.

Authors:  Hideki Wada; Tomotaka Dohi; Katsumi Miyauchi; Jun Shitara; Hirohisa Endo; Shinichiro Doi; Ryo Naito; Hirokazu Konishi; Shuta Tsuboi; Manabu Ogita; Takatoshi Kasai; Shinya Okazaki; Kikuo Isoda; Satoru Suwa; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2017-04-20       Impact factor: 2.037

2.  Structural insights into human serum albumin-mediated prostaglandin catalysis.

Authors:  Jinsheng Yang; Charles E Petersen; Chung-Eun Ha; Nadhipuram V Bhagavan
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

3.  Serum albumin concentration and incident type 2 diabetes risk: new findings from a population-based cohort study.

Authors:  Setor K Kunutsor; Hassan Khan; Jari A Laukkanen
Journal:  Diabetologia       Date:  2015-02-14       Impact factor: 10.122

4.  Age-Related Changes in Biomarkers: Longitudinal Data from a Population-Based Sample.

Authors:  Dana A Glei; Noreen Goldman; Yu-Hsuan Lin; Maxine Weinstein
Journal:  Res Aging       Date:  2011-05-01

5.  Plasma biomarkers of mouse aging.

Authors:  Juan Ding; John J Kopchick
Journal:  Age (Dordr)       Date:  2010-09-15

6.  Serum albumin levels are associated with cardioembolic and cryptogenic ischemic strokes: Northern Manhattan Study.

Authors:  Wei-Hai Xu; Chuanhui Dong; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco
Journal:  Stroke       Date:  2014-02-18       Impact factor: 7.914

7.  Serum albumin acts as a shuttle to enhance cholesterol efflux from cells.

Authors:  Sandhya Sankaranarayanan; Margarita de la Llera-Moya; Denise Drazul-Schrader; Michael C Phillips; Ginny Kellner-Weibel; George H Rothblat
Journal:  J Lipid Res       Date:  2013-01-03       Impact factor: 5.922

8.  Factors associated with high cardiovascular risk in a primarily African American, urban HIV-infected population.

Authors:  Shashwatee Bagchi; Shana Ab Burrowes; Lori E Fantry; Mian B Hossain; Gemechis H Tollera; Shyamasundaran Kottilil; C David Pauza; Michael Miller; Mona Baumgarten; Robert R Redfield
Journal:  SAGE Open Med       Date:  2017-08-10

9.  Effects of statins on the secretion of human serum albumin in cultured HepG2 cells.

Authors:  Chung-Eun Ha; Ji-Sook Ha; Andre G Theriault; Nadhipuram V Bhagavan
Journal:  J Biomed Sci       Date:  2009-03-16       Impact factor: 8.410

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.